Winner Medical Co., Ltd. (300888.SZ)
CNY 52.22
(0.27%)
CNY 52.22
(0.27%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 580.4 Million CNY | -64.84% |
| 2022 | 1.65 Billion CNY | 33.2% |
| 2021 | 1.23 Billion CNY | -67.48% |
| 2020 | 3.81 Billion CNY | 597.5% |
| 2019 | 546.29 Million CNY | 28.64% |
| 2018 | 424.68 Million CNY | -0.59% |
| 2017 | 427.2 Million CNY | 4.29% |
| 2016 | 409.64 Million CNY | 85.74% |
| 2015 | 220.53 Million CNY | 70.88% |
| 2014 | 129.05 Million CNY | 46.43% |
| 2013 | 88.13 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 182.42 Million CNY | 111.64% |
| 2024 Q3 | 168.81 Million CNY | -16.31% |
| 2024 Q2 | 201.72 Million CNY | 10.58% |
| 2023 Q1 | 376.93 Million CNY | -5.83% |
| 2023 Q4 | -1.56 Billion CNY | -206.9% |
| 2023 FY | 580.4 Million CNY | -64.84% |
| 2023 Q3 | 1.46 Billion CNY | 381.21% |
| 2023 Q2 | 304.67 Million CNY | -19.17% |
| 2022 Q4 | 400.28 Million CNY | 11.98% |
| 2022 Q3 | 357.46 Million CNY | -33.27% |
| 2022 Q2 | 535.72 Million CNY | 50.02% |
| 2022 Q1 | 357.1 Million CNY | 163.97% |
| 2022 FY | 1.65 Billion CNY | 33.2% |
| 2021 FY | 1.23 Billion CNY | -67.48% |
| 2021 Q3 | 343 Million CNY | 22.3% |
| 2021 Q4 | 135.27 Million CNY | -60.56% |
| 2021 Q1 | 480.58 Million CNY | -27.22% |
| 2021 Q2 | 280.45 Million CNY | -41.64% |
| 2020 Q2 | 713.41 Million CNY | 123.78% |
| 2020 FY | 3.81 Billion CNY | 597.5% |
| 2020 Q1 | 318.8 Million CNY | 124.94% |
| 2020 Q3 | 2.11 Billion CNY | 196.87% |
| 2020 Q4 | 660.31 Million CNY | -68.82% |
| 2019 Q4 | 141.72 Million CNY | -18.84% |
| 2019 FY | 546.29 Million CNY | 28.64% |
| 2019 Q3 | 174.63 Million CNY | 51.9% |
| 2019 Q2 | 114.96 Million CNY | 0.0% |
| 2019 Q1 | 114.96 Million CNY | 0.0% |
| 2018 FY | 424.68 Million CNY | -0.59% |
| 2017 FY | 427.2 Million CNY | 4.29% |
| 2016 FY | 409.64 Million CNY | 85.74% |
| 2015 FY | 220.53 Million CNY | 70.88% |
| 2014 FY | 129.05 Million CNY | 46.43% |
| 2013 FY | 88.13 Million CNY | 0.0% |